Table 3.
Clinical characteristics and demographics of two groups of patients.
| Control Group | NP Group | p Value | |
|---|---|---|---|
| n = 13 | n = 12 | ||
| Age (years) | 39.2 ± 8.9 | 38.2 ± 5.5 | 0.746 |
| BMI (kg/m2) | 21.8 ± 3.2 | 20.4 ± 1.1 | 0.145 |
| Smoking | 0 | 0 | |
| Hypertension | 0 | 0 | |
| Diabetes mellitus | 0 | 0 | |
| TNM staging | |||
| Stage 0 (DCIS) | 3 (23.1%) | 7 (58.3%) | 0.092 |
| Stage I | 3 (23.1%) | 4 (33.3%) | |
| Stage II | 4 (30.8%) | 1(8.3%) | |
| Stage III | 3 (23.1%) | 0 (0%) | |
| ER status | |||
| Positive | 8 (61.5%) | 6 (50%) | 0.561 |
| Negative | 5 (38.5%) | 6 (50%) | |
| PR status | |||
| Positive | 8 (61.5%) | 6 (50%) | 0.561 |
| Negative | 5 (38.5%) | 6 (50%) | |
| HER-2 status | |||
| Positive | 9 (69.2%) | 9 (75%) | 1.000 |
| Negative | 4 (30.8%) | 3 (25%) |
Data are presented as n (%) or mean ± standard deviation. NP, negative pressure; BMI, body mass index; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor-2.